A Randomized, Comparative, Open-label Study of IV Monofer® Administered as Maintenance Therapy by Single or Repeated Bolus Injections in Comparison With IV Iron Sucrose in Subjects With CKD-5D

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 351 participants.

Also called NCT01222884

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 351 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01222884
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
India (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01222884. Randomized; no masking; primary purpose treatment. Start 2011-06 (registry gives no type); primary completion 2013-10 (actual). Results posted on 2015-07-24.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Randomized, Comparative, Open-label Study of IV Monofer® Administered as Maintenance Therapy by Single or Repeated Bolus Injections in Comparison With IV Iron Sucrose in Subjects With CKD-5D
Condition
Chronic Kidney Disease Stage 5 (Dialysis Dependent)
Intervention (Drug)
Monofer
Intervention (Drug)
Iron sucrose
Lead sponsor
Pharmacosmos A/S (class: industry)

Record details

Record id
cardio:ct-nct01222884
Content hash
6fee3049c2751f7b013edfbd9b890bd9e64b478b09247d61f67e78b78c2e04a6